Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H17N3O4S |
InChIKeyIIAMBYTZHAPBQC-UHFFFAOYSA-N |
CAS Registry602293-00-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | AU | 24 Apr 2014 |